Rate My Professor Shelley Rose

During her time at the University of Otago, Rose contributed to significant research projects, including the OPTIMISE study, a multicentre trial comparing continuous glucose monitoring with intermittently scanned monitoring in youth and young adults with type 1 diabetes. Her key publications include 'Effect of 6 Months of Flash Glucose Monitoring in Youth With Type 1 Diabetes Entering Adulthood' (Diabetes Care, 2020), 'Impact of high-risk glycemic control on habitual sleep patterns and quality in youth with type 1 diabetes' (Pediatric Diabetes, 2021), 'The OPTIMISE study protocol: a multicentre optimisation trial comparing continuous glucose monitoring with intermittently scanned monitoring' (Journal of Diabetes & Metabolic Disorders, 2022), 'Use of intermittently scanned continuous glucose monitoring in young people with high-risk type 1 diabetes' (Diabetic Medicine, 2022), 'Impact of 6 months' Use of Intermittently Scanned Continuous Glucose Monitoring on Glycemia and Patient-Reported Outcomes' (2023), and co-authorship on the ISPAD Clinical Practice Consensus Guidelines 2022: Nutritional management in children and adolescents with diabetes. In 2022, she received the Freemasons New Zealand Fellowship in Paediatrics and Child Health for her research on glucose monitoring technology. Rose has served in research roles within paediatric endocrinology teams and now holds a senior clinical and professional leadership position at Te Whatu Ora | Health NZ, where she advocates for evidence-based nutrition interventions, dietitian prescribing, and equitable access to diabetes care. She is a member of the Dietitians Board of New Zealand and contributes to national and international clinical guidelines.